SOL J BARER Insider Trading Transactions
Get free email notifications about insider trading for SOL J BARER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SOL J BARER. SOL J BARER is Chief Operating Officer in CELGENE CORP /DE/ ($CELG) and Director in TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) and Director in AMICUS THERAPEUTICS INC ($FOLD) and Director in MEDGENICS, INC. ($MDGN) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in InspireMD, Inc. ($NSPR) and Director in CONTRAFECT Corp ($CFRX) and Director in NexImmune, Inc. ($NEXI) and Director in Cerecor Inc. ($CERC).
Latest Insider Trading Transactions of SOL J BARER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, GNMX, FOLD, CELG, CERC, CFRX, NSPR, NEXI, EDGE, TEVA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | CFRX | CONTRAFECT Corp | BARER SOL J | Director | Option Exercise | A | 3.86 | 25,000 | 96,500 | 25,000 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 217,570 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 82,204 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 164,408 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 894,036 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | C | 0.00 | 800,182 | 0 | 0 | |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 217,570 | 0 | 346,577 | 129 K to 346.6 K (+168.65 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | P | 17.00 | 60,000 | 1,020,000 | 1,538,013 | 1.5 M to 1.5 M (+4.06 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 337,365 | 0 | 1,478,013 | 1.1 M to 1.5 M (+29.58 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 82,204 | 0 | 1,140,648 | 1.1 M to 1.1 M (+7.77 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 164,408 | 0 | 1,058,444 | 894 K to 1.1 M (+18.39 %) |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 894,036 | 0 | 894,036 | 0 to 894 K |
Feb 19 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Buy | C | 0.00 | 800,182 | 0 | 1,367,814 | 567.6 K to 1.4 M (+140.97 %) |
Feb 16 2021 | NEXI | NexImmune, Inc. | BARER SOL J | Director | Option Exercise | A | 17.00 | 19,113 | 324,921 | 225,013 | |
Aug 13 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 23,133 | 0 | 0 | |
Aug 13 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | M | 0.00 | 23,133 | 0 | 277,433 | 254.3 K to 277.4 K (+9.10 %) |
Jun 19 2020 | CERC | Cerecor Inc. | BARER SOL J | Director | Option Exercise | A | 0.00 | 1,000,000 | 0 | 1,000,000 | |
Jun 19 2020 | CERC | Cerecor Inc. | BARER SOL J | Director | Option Exercise | A | 2.51 | 25,000 | 62,750 | 25,000 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 31,388 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | M | 0.00 | 31,388 | 0 | 254,300 | 222.9 K to 254.3 K (+14.08 %) |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | A | 0.00 | 22,565 | 0 | 22,565 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 2,470 | 0 | 0 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | M | 0.00 | 2,470 | 0 | 222,912 | 220.4 K to 222.9 K (+1.12 %) |
Feb 05 2020 | CERC | Cerecor Inc. | BARER SOL J | Director | Option Exercise | A | 3.98 | 500,000 | 1,990,000 | 500,000 | |
Feb 05 2020 | CERC | Cerecor Inc. | BARER SOL J | Director | Option Exercise | A | 3.98 | 500,000 | 1,990,000 | 500,000 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 2.84 | 74,912 | 212,750 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 1.55 | 100,000 | 155,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 1.32 | 80,000 | 105,600 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 4.83 | 80,000 | 386,400 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 7.01 | 80,000 | 560,800 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 6.50 | 15,000 | 97,500 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 7.25 | 15,000 | 108,750 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 5.22 | 200,000 | 1,044,000 | 0 | |
Feb 05 2020 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | D | 5.22 | 200,000 | 1,044,000 | 0 | |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Sell | S | 0.13 | 4,098,752 | 549,233 | 0 | 4.1 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Sell | S | 0.13 | 4,098,752 | 549,233 | 0 | 4.1 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | J | 0.00 | 2,551,020 | 0 | 4,098,752 | 1.5 M to 4.1 M (+164.82 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | J | 0.00 | 2,551,020 | 0 | 4,098,752 | 1.5 M to 4.1 M (+164.82 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Sell | J | 0.00 | 2,551,020 | 0 | 0 | 2.6 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Sell | J | 0.00 | 2,551,020 | 0 | 0 | 2.6 M to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 365,854 | 0 | 1,547,732 | 1.2 M to 1.5 M (+30.96 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 365,854 | 0 | 1,547,732 | 1.2 M to 1.5 M (+30.96 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 365,854 | 0 | 0 | 365.9 K to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 365,854 | 0 | 0 | 365.9 K to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 153,846 | 0 | 1,181,878 | 1 M to 1.2 M (+14.97 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 153,846 | 0 | 1,181,878 | 1 M to 1.2 M (+14.97 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 153,846 | 0 | 0 | 153.8 K to 0 (-100.00 %) |
Dec 09 2019 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Gift | G | 0.00 | 153,846 | 0 | 0 | 153.8 K to 0 (-100.00 %) |
Jun 13 2019 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | A | 0.00 | 31,388 | 0 | 31,388 | |
Jun 05 2019 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | P | 9.60 | 104,500 | 1,003,409 | 220,442 | 115.9 K to 220.4 K (+90.13 %) |
Jun 03 2019 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | P | 8.98 | 111,000 | 997,013 | 115,942 | 4.9 K to 115.9 K (+2,246.05 %) |
May 20 2019 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 2,780 | 0 | 0 | |
May 20 2019 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | M | 0.00 | 2,780 | 0 | 4,942 | 2.2 K to 4.9 K (+128.58 %) |
Mar 18 2019 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
Mar 18 2019 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | M | 0.00 | 20,000 | 0 | 678,075 | 658.1 K to 678.1 K (+3.04 %) |
Sep 05 2018 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 2,162 | 0 | 0 | |
Sep 05 2018 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | M | 0.00 | 2,162 | 0 | 2,162 | 0 to 2.2 K |
Aug 17 2018 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | P | 0.96 | 2,551,020 | 2,448,979 | 2,551,020 | 0 to 2.6 M |
Aug 15 2018 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Jun 20 2018 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | A | 1.10 | 40,000 | 44,000 | 40,000 | |
Jun 20 2018 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | A | 1.10 | 40,000 | 44,000 | 40,000 | |
Jun 18 2018 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | A | 1.55 | 100,000 | 155,000 | 100,000 | |
Jun 07 2018 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | A | 0.00 | 17,565 | 0 | 17,565 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | P | 2.84 | 74,912 | 212,750 | 74,912 | |
Oct 18 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | P | 1.26 | 421,032 | 530,500 | 1,028,032 | 607 K to 1 M (+69.36 %) |
Aug 10 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Option Exercise | A | 1.32 | 80,000 | 105,600 | 80,000 | |
Jul 26 2017 | CFRX | CONTRAFECT Corp | BARER SOL J | Director | Option Exercise | P | 1.55 | 20,000 | 31,000 | 20,000 | |
Jul 26 2017 | CFRX | CONTRAFECT Corp | BARER SOL J | Director | Buy | P | 1.24 | 40,000 | 49,600 | 815,933 | 775.9 K to 815.9 K (+5.16 %) |
Jul 10 2017 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | X | 2.39 | 12,530 | 29,947 | 0 | |
Jul 10 2017 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | X | 2.39 | 12,530 | 29,947 | 658,075 | 645.5 K to 658.1 K (+1.94 %) |
Jun 21 2017 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | A | 10.15 | 30,000 | 304,500 | 30,000 | |
May 01 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | P | 1.57 | 100,000 | 156,670 | 607,000 | 507 K to 607 K (+19.72 %) |
Apr 27 2017 | GNMX | Aevi Genomic Medic ... | BARER SOL J | Director | Buy | P | 1.54 | 100,000 | 154,340 | 507,000 | 407 K to 507 K (+24.57 %) |
Dec 08 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | A | 3.04 | 20,000 | 60,800 | 20,000 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 17.64 | 9,988 | 176,188 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 19.25 | 19,927 | 383,595 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Sell | D | 0.00 | 29,890 | 0 | 0 | 29.9 K to 0 (-100.00 %) |
Jul 11 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | P | 0.20 | 3,333,300 | 666,660 | 3,333,300 | |
Jul 11 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | P | 0.33 | 33,333 | 11,000 | 33,333 | |
Jul 05 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | A | 0.33 | 122,282 | 40,353 | 122,282 | |
Jun 23 2016 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | A | 9.34 | 30,000 | 280,200 | 30,000 | |
Jun 23 2016 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | A | 9.34 | 30,000 | 280,200 | 30,000 | |
Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
Mar 23 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | P | 0.59 | 423,729 | 250,000 | 423,729 | |
Mar 23 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Buy | P | 0.59 | 847,458 | 500,000 | 1,141,690 | 294.2 K to 1.1 M (+288.02 %) |
Apr 19 2016 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | A | 4.83 | 80,000 | 386,400 | 80,000 | |
Jan 28 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | D | 7.20 | 9,161 | 65,959 | 0 | |
Jan 28 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | D | 7.80 | 4,162 | 32,464 | 0 | |
Jan 28 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | D | 27.50 | 10,000 | 275,000 | 0 | |
Jan 28 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | D | 31.00 | 8,500 | 263,500 | 0 | |
Jan 28 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | D | 31.60 | 1,250 | 39,500 | 0 | |
Jan 28 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | D | 100.00 | 12,500 | 1,250,000 | 0 | |
Jan 28 2016 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Grant | A | 0.00 | 1 | 0 | 294,232 | 294.2 K to 294.2 K (0.00 %) |
Oct 08 2015 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 6.50 | 153,846 | 999,999 | 153,846 | 0 to 153.8 K |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | C | 0.00 | 144,086 | 0 | 0 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | C | 0.00 | 65,809 | 0 | 0 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | C | 0.00 | 114,285 | 0 | 0 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Option Exercise | C | 0.00 | 480,000 | 0 | 0 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | J | 6.17 | 12,735 | 78,575 | 645,545 | 632.8 K to 645.5 K (+2.01 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | P | 11.00 | 45,000 | 495,000 | 632,810 | 587.8 K to 632.8 K (+7.66 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | C | 0.00 | 105,319 | 0 | 587,810 | 482.5 K to 587.8 K (+21.83 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | C | 0.00 | 48,103 | 0 | 482,491 | 434.4 K to 482.5 K (+11.07 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | C | 0.00 | 83,536 | 0 | 434,388 | 350.9 K to 434.4 K (+23.81 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | BARER SOL J | Director | Buy | C | 0.00 | 350,852 | 0 | 350,852 | 0 to 350.9 K |
Oct 02 2015 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | A | 0.17 | 81,549 | 13,863 | 81,549 | |
Jul 02 2015 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | A | 0.28 | 49,662 | 13,905 | 49,662 | |
Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
Apr 06 2015 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | A | 0.32 | 43,889 | 14,044 | 43,889 | |
Mar 23 2015 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 8.45 | 50,000 | 422,500 | 407,000 | 357 K to 407 K (+14.01 %) |
Mar 11 2015 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Option Exercise | P | 0.55 | 2,500,000 | 1,375,000 | 2,500,000 | |
Mar 11 2015 | NSPR | InspireMD, Inc. | BARER SOL J | Director | Buy | P | 0.00 | 2,500,000 | 0 | 2,942,308 | 442.3 K to 2.9 M (+565.22 %) |
Nov 13 2003 | CELG | CELGENE CORP /DE/ | BARER SOL J | Chief Operating Off ... | Option Exercise | A | 2.50 | 10,000 | 25,000 | 0 | |
Nov 13 2003 | CELG | CELGENE CORP /DE/ | BARER SOL J | Chief Operating Off ... | Buy | M | 2.50 | 10,000 | 25,000 | 228,568 | 218.6 K to 228.6 K (+4.58 %) |
Page: 1